Inhibitory effects of neurotransmitters and steroids on human CYP2A6

Drug Metabolism and Disposition

Volumn 35, Issue 4, 2007, Pages 508-514

  Higashi, Eriko ^a   Nakajima, Miki ^a   Katoh, Miki ^a   Tokudome, Shogo ^b   Yokoi, Tsuyoshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3' HYDROXYCOTININE; ADRENALIN; ANDROSTANEDIOL; ANDROSTENEDIONE; CORTICOSTERONE; COUMARIN 7 HYDROXYLASE; CYTOCHROME P450 2A6; DOPAMINE; ESTRADIOL; ESTRIOL; ESTRONE; HISTAMINE; LEVODOPA; MELATONIN; NEUROTRANSMITTER; NICOTINE; NORADRENALIN; PROGESTERONE; SEROTONIN; STEROID HORMONE; TESTOSTERONE; TRYPTAMINE; TRYPTOPHAN; TYROSINE;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG HYDROXYLATION; DRUG METABOLISM; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALDEHYDE OXIDASE; ANDROGENS; ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BINDING, COMPETITIVE; CELL LINE; CORTICOSTERONE; COUMARINS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EPINEPHRINE; ESTROGENS; HISTAMINE; HORMONES; HUMANS; HYDROXYLATION; INSECTS; LIVER; MICROSOMES, LIVER; MIXED FUNCTION OXYGENASES; MOLECULAR STRUCTURE; NEUROTRANSMITTER AGENTS; NICOTINE; NOREPINEPHRINE; PHENOTYPE; RECOMBINANT PROTEINS; SEROTONIN; TRYPTAMINES;

HEXAPODA;

EID: 34047163480     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.106.014084     Document Type: Article

References (37)

1. Agúndez JA, Gallardo L, Martínez C, Gervasini G, and Benítez J (1998) Modulation of CYP1A2 enzyme activity by indoleamines: inhibition by serotonin and tryptamine. Pharmacogenetics 8:251-258.
2. Benowitz NL, Lessov-Schlaggar CN, Swan GE, and Jacob P 3rd (2006) Female sex and oral contraceptive use accelerate nicotine metabolism. Clin Pharmacol Ther 79:480-488.
3. 1′(5′) iminium ion. Biochem Biophys Res Commun 91:991-996.
4. Curtin F, Walker JP, and Schulz P (1996) Day-to-day intraindividual reliability and interindividual differences in monoamines excretion. J Affect Disord 38:173-178.
5. Di Chiara G (2000) Role of dopamine in the behavioural actions of nicotine related to addiction. Eur J Pharmacol 393:295-314.
6. Dempsey D, Jacob P 3rd, and Benowitz NL (2002) Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther 301:594-598.
7. Ensinger H, Lindner KH, Dirks B, Kilian J, Grunert A, and Ahnefeld FW (1992) Adrenaline: relationship between infusion rate, plasma concentration, metabolic and haemodynamic effects in volunteers. Eur J Anaesthesiol 9:435-446.
8. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf AP, et al. (1996a) Inhibition of monoamine oxidase B in the brains of smokers. Nature (Lond) 379:733-736.
9. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, Shea C, Alexoff D, MacGregor R, Schlyer D, Zezulkova I, et al. (1996b) Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci USA 93:14065-14069.
10. Gervasini G, Martínez C, Agúndez JA, García-Gamito FJ, and Benítez J (2001) Inhibition of cytochrome P450 2C9 activity in vitro by 5-hydroxytryptamine and adrenaline. Pharmacogenetics 11:29-37.
11. Johnston JP (1968) Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol 17:1285-1297.
12. Lee AJ, Cai MX, Thomas PE, Conney AH, and Zhu BT (2003) Characterization of the oxidative metabolites of 17β-estradiol and estrone formed by 15 selectively expressed human cytochrome P450 isoforms. Endocrinology 144:3382-3398.
13. Martínez C, Agúndez JA, Gervasini G, Martín R, and Benítez J (1997) Tryptamine: a possible endogenous substrate for CYP2D6. Pharmacogenetics 7:85-93.
14. Martínez C, Gervasini G, Agúndez JA, Carrillo JA, Ramos SI, García-Gamito FJ, Gallardo L, and Benítez J (2000) Modulation of midazolam 1-hydroxylation activity in vitro by neurotransmitters and precursors. Eur J Clin Pharmacol 56:145-151.
15. Miksys S and Tyndale RF (2004) The unique regulation of brain cytochrome P450 2 (CYP2) family enzymes by drugs and genetics. Drug Metab Rev 36:313-333.
16. Mills MH, Finlay DC, and Haddad PR (1991) Determination of melatonin and monoamines in rat pineal using reversed-phase ion-interaction chromatography with fluorescence detection. J Chromatogr 564:93-102.
17. Mousseau DD (1993) Tryptamine: a metabolite of tryptophan implicated in various neuropsychiatric disorders. Metab Brain Dis 8:1-44.
18. Murphy SE, Raulinaitis V, and Brown KM (2005) Nicotine 5′-oxidation and methyl oxidation by P450 2A enzymes. Drug Metab Dispos 33:1166-1173.
19. Nakajima M, Fukami T, Yamanaka H, Higashi E, Sakai H, Yoshida R, Kwon JT, McLeod HL, and Yokoi T (2006a) Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations. Clin Pharmacol Ther 80:282-297.
20. Nakajima M, Itoh M, Sakai H, Fukami T, Katoh M, Yamazaki H, Kadlubar FF, Imaoka S, Funae Y, and Yokoi T (2006b) CYP2A13 expressed in human bladder metabolically activates 4-aminobiphenyl. Int J Cancer 119:2520-2526.
21. Nakajima M, Itoh M, Yamanaka H, Fukami T, Tokudome S, Yamamoto Y, Yamamoto H, and Yokoi T (2006c) Isoflavones inhibit nicotine C-oxidation catalyzed by human CYP2A6. J Clin Pharmacol 46:337-344.
22. Nakajima M, Kuroiwa Y, and Yokoi T (2002) Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6. Drug Metab Rev 34:865-877.
23. Nakajima M, Yamamoto T, Nunoya K-I, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T, and Kuroiwa Y (1996a) Characterization of CYP2A6 involved in 3′-hydroxylation of cotinine in human liver microsomes. J Pharmacol Exp Ther 277:1010-1015.
24. Nakajima M, Yamamoto T, Nunoya K-I, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T, and Kuroiwa Y (1996b) Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab Dispos 24:1212-1217.
25. Nakamura H, Nakasa H, Ishii I, Ariyoshi N, Igarashi T, Ohmori S, and Kitada M (2002) Effects of endogenous steroids on CYP3A4-mediated drug metabolism by human liver microsomes. Drug Metab Dispos 30:534-540.
26. Niwa T, Yabusaki Y, Honma K, Matsuo N, Tatsuta K, Ishibashi F, and Katagiri M (1998) Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones. Xenobiotica 28:539-547.
27. Obach RS (2004) Potent inhibition of human liver aldehyde oxidase by raloxifene. Drug Metab Dispos 32:89-97.
28. Ohyama K, Nakajima M, Suzuki M, Shimada N, Yamazaki H, and Yokoi T (2000) Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions. Br J Clin Pharmacol 49:244-253.
29. Shimada T, Yamazaki H, Mimura M, Inui Y, and Guengerich FP (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423.
30. Yamanaka H, Nakajima M, Fukami T, Sakai H, Nakamura A, Katoh M, Takamiya M, Aoki Y, and Yokoi T (2005) CYP2A6 and CYP2B6 are involved in nornicotine formation from nicotine in humans: interindividual differences in these contributions. Drug Metab Dispos 33:1811-1818.
31. Yamanaka H, Nakajima M, Nishimura K, Yoshida R, Fukami T, Katoh M, and Yokoi T (2004) Metabolic profile of nicotine in subjects whose CYP2A6 gene is deleted. Eur J Pharm Sci 22:419-425.
32. Yamazaki H, Shaw PM, Guengerich FP, and Shimada T (1998) Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Chem Res Toxicol 11:658-665.
33. Youdim MB and Riederer P (1993) Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition. J Neural Transm Gen Sect 91:181-195.
34. Yu AM, Granvil CP, Haining RL, Krausz KW, Corchero J, Kupfer A, Idle JR, and Gonzalez FJ (2003) The relative contribution of monoamine oxidase and cytochrome P450 isozymes to the metabolic deamination of the trace amine tryptamine. J Pharmacol Exp Ther 304:539-546.
35. Yun CH, Shimada T, and Guengerich FP (1991) Purification and characterization of human liver microsomal cytochrome P-450 2A6. Mol Pharmacol 40:679-685.
36. Zeman MV, Hiraki L, and Sellers EM (2002) Gender differences in tobacco smoking: higher relative exposure to smoke than nicotine in women. J Womens Health Gend Based Med 11:147-153.
37. Zhang W, Kilicarslan T, Tyndale RF, and Sellers EM (2001) Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro. Drug Metab Dispos 29:897-902.